DOCS vs. BLND, TEM, RMG, VTY, SPT, GEN, WIX, YOU, CNIC, and SST
Should you be buying Dr. Martens stock or one of its competitors? The main competitors of Dr. Martens include British Land (BLND), Templeton Emerging Markets Investment Trust (TEM), Royal Mail (RMG), Vistry Group (VTY), Spirent Communications (SPT), Genuit Group (GEN), Wickes Group (WIX), YouGov (YOU), CentralNic Group (CNIC), and Scottish Oriental Smaller Cos (SST). These companies are all part of the "computer software" industry.
Dr. Martens vs. Its Competitors
Dr. Martens (LON:DOCS) and British Land (LON:BLND) are both computer software companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.
Dr. Martens pays an annual dividend of GBX 0.02 per share and has a dividend yield of 0.0%. British Land pays an annual dividend of GBX 0.23 per share and has a dividend yield of 0.1%. Dr. Martens pays out 368.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. British Land pays out 65.4% of its earnings in the form of a dividend. British Land is clearly the better dividend stock, given its higher yield and lower payout ratio.
British Land has a net margin of 171.35% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat British Land's return on equity.
32.1% of Dr. Martens shares are held by institutional investors. Comparatively, 45.9% of British Land shares are held by institutional investors. 2.8% of Dr. Martens shares are held by insiders. Comparatively, 0.5% of British Land shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
British Land has lower revenue, but higher earnings than Dr. Martens. British Land is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.
In the previous week, British Land had 1 more articles in the media than Dr. Martens. MarketBeat recorded 6 mentions for British Land and 5 mentions for Dr. Martens. British Land's average media sentiment score of 1.44 beat Dr. Martens' score of 0.85 indicating that British Land is being referred to more favorably in the news media.
Dr. Martens currently has a consensus target price of GBX 6,000, suggesting a potential upside of 6,369.00%. British Land has a consensus target price of GBX 480, suggesting a potential upside of 39.53%. Given Dr. Martens' higher probable upside, research analysts clearly believe Dr. Martens is more favorable than British Land.
Dr. Martens has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, British Land has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500.
Summary
British Land beats Dr. Martens on 11 of the 17 factors compared between the two stocks.
Get Dr. Martens News Delivered to You Automatically
Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Dr. Martens Competitors List
Related Companies and Tools
This page (LON:DOCS) was last updated on 9/19/2025 by MarketBeat.com Staff